Cardiovascular disease (CVD)

via Started within 48 hours of stroke, neuroprotective medication helped brain cells, recovery Research Highlights: In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting within 48 hours of stroke symptoms, had a higher proportion of ...

via High-dose therapy had lasting benefits for infants with stroke before or soon after birthResearch Highlights: For infants and toddlers who have had a stroke, a new treatment that restricted the use of their stronger arm and hand to encourage them to use their stroke-affected arm and hand, combined with high-dosage and a specific type of...

via New medication may reduce chances of a second clot-caused stroke without bleeding riskResearch Highlights: When added to standard blood-thinning medications such as aspirin, the new anti-clotting medication asundexian reduced the risk of a second stroke by reducing the formation of blood clots without increasing the risk of...